Peritoneal dialysis solution biocompatibility testing: A realistic alternative?

Peritoneal Dialysis International

Volumn 25, Issue 4, 2005, Pages 348-351

  Topley, Nicholas ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BICARBONATE; BUFFER; DIALYSIS FLUID; GLUCOSE; INTERLEUKIN 6; LACTIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

BIOCOMPATIBILITY; CELL CULTURE; DIALYSIS MEMBRANE; EX VIVO STUDY; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; LEUKOCYTE FUNCTION; MEDIATOR RELEASE; MESOTHELIUM CELL; NONHUMAN; NOTE; OSMOLALITY; PERITONEAL DIALYSIS; PERITONITIS; PH; PRIORITY JOURNAL; RELIABILITY; VALIDATION PROCESS;

EID: 23744498500     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500408     Document Type: Note

References (47)

1. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
2. Ing BL, Gupta DK, Nawab ZM, Zhou FQ, Rahman MA, Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988; 11:351-4.
3. Jörres A, Jörres D, Gahl GM, Kessel M, Muller C, Kottgen E, et al. Leukotriene B4 and tumor necrosis factor release from Leukocytes: effect of peritoneal dialysate. Nephron 1991; 58:276-82.
4. Liberek T, Topley N, Jorres A, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 1993; 3:1508-15.
5. Liberek T, Topley N, Jorres A, Petersen M, Coles GA, Gahl GM, et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
6. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34:404-11.
7. van Bronswijk H, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, van der Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
8. van Bronswijk H, Verbrugh HA, Heezius EC, Verkooyen RP, van der Meulen J, Verhoef J. Host defence in CAPD treatment: the effect of the dialysate on cell function. Contrib Nephrol 1990; 85:67-72.
9. van Bronswjjk H, Verbrugh HA, Heezius HC, van der Meulen J, Oe PL, Verhoef J. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7:368-73.
10. Wieslander A. Cytotoxicity of glucose degradation products in PD-fluids. In: Nephrology. Lund: University of Lund; 1995.
11. Hjelle JT, Golinska BT, Waters DC, Steidley KR, McCarroll DR, Dobbie JW. Isolation and propagation in vitro of peritoneal mesothelial cells. Perit Dial Int 1989; 9:341-7
12. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
13. Beavis MJ, Topley N. Isolation, culture and characterisation of human peritoneal mesothelial cells. In: Doyle A, Griffiths JB, Newell DG, eds. Cell and Tissue Culture: Laboratory Procedures. Specialised Vertebrate Cultures-Integumentary Systems and Musculartissue. Chichester, UK: John Wiley; 1995.
14. Jorres A, Ludat K, Lang J, Sander K, Gahl GM, Frei U, et al. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7:2192-201.
15. Topley N. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int 1997; 17:42-7.
16. Topley N, Kaur D, Petersen MM, Jorres A, Passlick-Deetjen J, Coles GA, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49:1447-56.
17. Betjes MGH, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hart M, et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor a, interleukin-1, and medium conditioned by macrophages co-cultured with Staphylococcus epidermidis. J Infect Dis 1993; 168:1202-10.
18. Topley N, Brown Z, Jorres A, Westwick J, Davies M, Coles GA, et al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 1993; 142: 1876-86.
19. Topley N, Floege J, Wessel K, Hass R, Radeke HH, Kaever V, et al. Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1. J Immunol 1989; 143:1989-95.
20. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993; 43:226-33.
21. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59:463-70.
22. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, Sitter T. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron 2001; 87:346-51.
23. Ito T, Yorioka N, Yamamoto M, Kataoka K, Yamakido M. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 2000; 11:1969-79.
24. Kumano K, Schiller B, Hjelle JT, Moran J. Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. Blood Purif 1996; 14:165-9.
25. Sitter T, Haslinger B, Mandl S, Fricke H, Held E, Sellmayer A. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity. J Am Soc Nephrol 1998; 9:2005-12.
26. Sitter T, Mandl-Weber S, Wornle M, Haslinger B, Goedde M, Kooistra T. D-glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells. Thromb Haemost 1999; 82:1171-6.
27. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11:729-39.
28. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
29. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63:1404-16.
30. Topley N. What is the ideal technique for testing the biocompatibitity of peritoneal dialysis solutions. Perit Dial Int 1995; 15:205-9.
31. Ahmed MI, Rawal PA, Patel NM, Yu AW, Abraham M, Harvey VC, et al. In vitro buffering capacity of residual peritoneal dialysis fluid: implications for peritoneal dialysis therapy. Artif Organs 1992; 16:416-18.
32. Jorres A, Topley N, Steenweg L, Muller C, Kottgen E, Gahl GM. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992; 12:80-5.
33. Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1995; 47:282-93.
34. Fusshoeller A, Baehr J, Grabensee B, Plum J. Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int 2005; 25:387-93.
35. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14:705-14.
36. Breborowicz A, Breborowicz M, Pyda M, Polubinska A, Oreopoulos D. Limitations of CA125 as an index of peritoneal mesothelial cell mass. Nephron Clin Pract 2005; 100:c46-c51.
37. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997; 51:888-93.
38. Topley N, Michael D, Bowen T. CA125: holy grail or a poisoned chalice. Nephron Clin Pract 2005; 100:c52-c54.
39. Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beelen RH, Krediet RT. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995; 10:64-9.
40. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506.
41. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
42. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
43. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; 84:158-61.
44. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT; Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88:S43-9.
45. Jones S, Holmes CJ, Mackenzie RK, Stead R, Coles GA, Williams JD, et al. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol 2002; 13(Suppl 1):S97-103.
46. MacKenzie RK, Holmes CJ, Moseley A, Jenkins JP, Williams JD, Coles GA, et al. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion. J Am Soc Nephrol 1998; 9:1499-506.
47. Liberek T, Lichodziejewska-Niemierko M, Knopinska-Posluszny W, Schaub TP, Kirchgessner J, Passlick-Deetjen J, et al. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid. Perit Dial Int 2002; 22:663-9.